TELA Bio to Participate in Upcoming Investor Conferences

Rhea-AI Summary

TELA Bio, Inc. (NASDAQ: TELA), a medical technology company focused on innovative tissue reinforcement materials, will participate in two investor conferences. The management will present at the UBS Global Healthcare Virtual Conference on May 24, 2021, at 8:00 AM EST. The Jefferies Virtual Healthcare Conference is scheduled for June 3, 2021, at 3:30 PM EST. Both presentations will be accessible via the company’s investor relations website. TELA Bio aims to enhance clinical outcomes in soft tissue reconstruction with its OviTex® products.

News Market Reaction – TELA

-0.08%

-0.08% Session move

In the trading session that priced this news, TELA declined 0.08%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MALVERN, Pa., May 21, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA"), a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction, today announced that the Company plans to participate in two upcoming investor conferences.

TELA Bio's management will be participating in the UBS Global Healthcare Virtual Conference on Monday, May 24, 2021 at 8:00 AM EST. Interested parties can access the live and archived webcast at ir.telabio.com.

TELA Bio's management is also scheduled to present at the Jefferies Virtual Healthcare Conference on Thursday, June 3, 2021 at 3:30 PM EST. Interested parties can access the live and archived webcast at ir.telabio.com.

About TELA Bio, Inc.

TELA Bio Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on designing, developing, and marketing innovative tissue reinforcement materials to address unmet needs in soft tissue reconstruction. The company is committed to providing patients with advanced, economically effective biologic material repair solutions to minimize long-term exposure to permanent synthetic materials and improve clinical outcomes. TELA Bio's OviTex® and OviTex PRS Reinforced Tissue Matrix products are purposefully designed to address the shortcomings of existing reinforcement materials in hernia repair, abdominal wall reconstruction, and plastic and reconstructive surgery. For more information, visit www.telabio.com.

TELA Bio Contact
Nora Brennan
Chief Financial Officer
TELA Bio, Inc.
484-320-2930

Investor Contact
Greg Chodaczek
347-620-7010 
ir@telabio.com

FAQ

What dates will TELA participate in investor conferences?

TELA Bio will participate in the UBS Global Healthcare Virtual Conference on May 24, 2021, and the Jefferies Virtual Healthcare Conference on June 3, 2021.

What time is TELA's presentation at the UBS Conference?

TELA's presentation at the UBS Global Healthcare Virtual Conference is scheduled for May 24, 2021, at 8:00 AM EST.

Where can I access TELA's conference presentations?

You can access TELA's conference presentations live and archived at their investor relations website.

What is TELA Bio known for?

TELA Bio is known for designing and marketing innovative tissue reinforcement materials for soft tissue reconstruction.

How does TELA's OviTex® product enhance tissue reconstruction?

OviTex® products are designed to address issues with existing materials in hernia repair and abdominal wall reconstruction.